ADAM12 overexpression does not improve outcome in mice with laminin α2-deficient muscular dystrophy

Neuromuscular Disorders

Volumn 15, Issue 11, 2005, Pages 786-789

  Guo, Ling T ^a   Shelton, G Diane ^b   Wewer, Ulla M ^c   Engvall, Eva ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ADAM12 (A Disintegrin And Metalloprotease); Laminin 2; Muscular dystrophy; Regeneration

Indexed keywords

A DISINTEGRIN AND METALLOPROTEASE 12; DYSTROPHIN; LAMININ ALPHA2; METALLOPROTEINASE; MYOSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; KNOCKOUT MOUSE; MOUSE; MUSCLE CELL; MUSCLE DISEASE; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAM PROTEINS; AGE FACTORS; ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; LAMININ; MICE; MICE, KNOCKOUT; MUSCULAR DYSTROPHY, ANIMAL; REGENERATION;

EID: 26944447114     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2005.06.019     Document Type: Article

References (28)

1. M.A. Hauser, and J.S. Chamberlain Progress towards gene therapy for Duchenne muscular dystrophy J Endocrinol 149 1996 373 378
2. D.M. Escolar, and C.G. Scacheri Pharmacologic and genetic therapy for childhood muscular dystrophies Curr Neurol Neurosci Rep 1 2001 168 174
3. F. Muntoni, I. Fisher, J.E. Morgan, and D. Abraham Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research Neuromuscul Disord 12 Suppl. 1 2002 S162 S165
4. K.J. Perkins, and K.E. Davies The role of utrophin in the potential therapy of Duchenne muscular dystrophy Neuromuscul Disord 12 Suppl. 1 2002 S78 S89
5. T.S. Khurana, and K.E. Davies Pharmacological strategies for muscular dystrophy Nat Rev Drug Discov 2 2003 379 390
6. E. Engvall, and U.M. Wewer The new frontier in muscular dystrophy research: booster genes FASEB J 17 2003 1579 1584
7. G.A. Cox, Y. Sunada, K.P. Campbell, and J.S. Chamberlain Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy Nat Genet 8 1994 333 339
8. D.S. Greenberg, Y. Sunada, K.P. Campbell, D. Yaffe, and U. Nudel Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice Nat Genet 8 1994 340 344
9. K. Hoyte, V. Jayasinha, B. Xia, and P.T. Martin Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice Am J Pathol 164 2004 711 718
10. W. Kuang, H. Xu, and P.H. Vachon Merosin deficient congenital muscular dystrophy; partial genetic correction in two mouse models J Clin Invest 102 1998 844 852
11. F. Muntoni, and T. Voit The congenital muscular dystrophies in 2004: a century of exciting progress Neuromuscul Disord 14 2004 635 649
12. L.T. Guo, X.U. Zhang, and W. Kuang Laminin α2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice Neuromuscul Disord 13 2003 207 215
13. J. Moll, P. Barzaghi, and S. Lin Agrin rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy Nature 413 2001 302 307
14. M. Girgenrath, J.A. Dominov, C.A. Kostek, and J. Boone Miller Inhibition of apoptosis improves outcome in a mouse model of congenital muscular dystrophy J Clin Invest 114 2004 1635 1639
15. J.T. Vilquin, I. Kinoshita, and B. Roy Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation J Cell Biol 133 1996 185 197
16. B. Moghadaszadeh, R. Albrechtsen, and L.T. Guo Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased a7 integrin, utrophin, and associated glycoproteins Hum Mol Genet 12 2003 2467 2479
17. A. Bornemann, R. Kuschel, and A. Fujisawa-Sehara Analysis for transcript expression of meltrin alpha in normal, regenerating, and denervated rat muscle J Muscle Res Cell Motil 21 2000 475 480
18. T. Kurisaki, A. Masuda, and K. Sudo Phenotypic analysis of meltrin a (ADAM12)-deficient mice: involvement of metrin a in adipogenesis and myogenesis Mol Cell Biol 23 2003 55 61
19. P. Kronqvist, N. Kawaguchi, and R. Albrechtsen ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice Am J Pathol 161 2002 1535 1540
20. W. Kuang, H. Xu, J.-T. Vilquin, and E. Engvall Activation of the lama2 gene in muscle regeneration; abortive regeneration in laminin α2-deficiency Lab Invest 79 1999 1601 1614
21. L.A. Liu, and E. Engvall Sarcoglycan isoforms in skeletal muscle J Biol Chem 274 1999 38171 38176
22. B.J. Gilpin, F. Loechel, M.-G. Mattei, E. Engvall, R. Albrechtsen, and U.M. Wewer A novel secreted form of human ADAM12 (meltrin α) provokes myogenesis in vivo J Biol Chem 273 1998 157 166
23. C.C. Lee, F. Pons, and P.G. Jones Mdx transgenic mouse: restoration of recombinant dystrophin to the dystrophic muscle Hum Gene Ther 4 1993 273 281
24. Z.F. Li, G.D. Shelton, and E. Engvall Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality Am J Pathol 166 2005 491 497
25. S. Bogdanovich, T.O. Krag, and E.R. Barton Functional improvement of dystrophic muscle by myostatin blockade Nature 420 2002 418 421
26. K.R. Wagner, A.C. McPherron, N. Winik, and S.J. Lee Loss of myostatin attenuates severity of muscular dystrophy in mdx mice Ann Neurol 52 2002 832 836
27. Y.-W. Chen, P. Zhao, R. Borup, and E.P. Hoffman Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology J Cell Biol 151 2000 1321 1336
28. M.J. Spencer, and J.G. Tidball Do immune cells promote the pathologies of dystrophin deficient myopathies? Neuromuscul Disord 11 2001 556 564